sprycel 20mg tablets
bristol-myers squibb pharmaceuticals ltd - dasatinib - tablet - 20mg
sprycel 50mg tablets
bristol-myers squibb pharmaceuticals ltd - dasatinib - tablet - 50mg
sprycel 100mg tablets
bristol-myers squibb pharmaceuticals ltd - dasatinib - tablet - 100mg
sprycel 140mg tablets
bristol-myers squibb pharmaceuticals ltd - dasatinib - tablet - 140mg
sprycel 80mg tablets
bristol-myers squibb pharmaceuticals ltd - dasatinib - tablet - 80mg
sprycel 100 mg
bristol, myers squibb (israel) limited, israel - dasatinib - film coated tablets - dasatinib 100 mg - dasatinib - dasatinib - treatment of adult patients with : * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.
sprycel tablets 20mg
bristol-myers squibb (singapore) pte. ltd. - dasatinib - tablet, film coated - 20 mg - dasatinib 20 mg
sprycel tablets 50mg
bristol-myers squibb (singapore) pte. ltd. - dasatinib - tablet, film coated - 50mg per tab - dasatinib 50mg per tab
sprycel tablets 70mg
bristol-myers squibb (singapore) pte. ltd. - dasatinib - tablet, film coated - 70mg/tab - dasatinib 70mg/tab
sprycel 70mg tablets
bristol-myers squibb pharmaceuticals ltd - dasatinib - tablet - 70mg